Prof. Dr. Steffi Lehmann
Prof. Dr. Steffi Lehmann
ZHAW
School of Life Sciences and Facility Management
Section for Pharmaceutical Technology and Pharmacology
Einsiedlerstrasse 31
8820 Wädenswil
Work at ZHAW
Position
- Head of Pharmaceutical Technology / Pharmacology Group
- Head of MSc Specialization in Pharmaceutical Biotechnology
Professional development teaching
Projects
- PERISINK – Control of the Peripheral sink and thus serum half-life of biologics via harnessing glycan-specific internalisation / Project leader / ongoing
- Adcancing drug development: 3D CoSeedis Immuno-Micro-Tumor System / Project leader / ongoing
- Zebrafish larvae for drug screening / Project leader / ongoing
- Local brain retention for better brain cancer drugs / Deputy project leader / ongoing
- Imaging of CAR macrophage efficacy / Project leader / completed
- SpectralPad / Co-project leader / completed
- Targeting Gram-negative bacteria / Deputy project leader / completed
- Novel phage derived antimicrobials / Project leader / completed
- Active modified surfaces for contained drug release / Project leader / completed
- “One-tube" luminescent reporter phage testing platform for on-site, lab-free environmental monitoring of Listeria spp. / Co-project leader / completed
- Extracellular vesicles for targeted delivery of new antimicrobials / Project leader / completed
- Infused Drinking Water from Dropz / Deputy project leader / completed
- Development of novel tablet formulations for the detection of pathogenic bacteria / Project leader / completed
- Preventing capsular contracture by coating of silicone implants with bioglass / Project leader / completed
Publications
Articles in scientific journal, peer-reviewed
- Zwicky, J., Fehr, D., Albert, I., Lehmann, S., Witthauer, L., & Bonmarin, M. (2026). Multimodal optical system for quantitative discrimination of bilirubin species. Biomedical Optics Express, 17(3), 1462–1475. https://doi.org/10.1364/boe.583874
- Roehrig, C., Huemer, M., Lorgé, D., Arn, F., Heinrich, N., Selvakumar, L., Gasser, L., Hauswirth, P., Chang, C.-C., Schweizer, T. A., Eichenseher, F., Lehmann, S., Zinkernagel, A. S., & Schmelcher, M. (2024). MEndoB, a chimeric lysin featuring a novel domain architecture and superior activity for the treatment of staphylococcal infections. mBio, 15(2), e02540–23. https://doi.org/10.1128/mbio.02540-23
- Sabani, B., Brand, M., Albert, I., Inderbitzin, J., Eichenseher, F., Schmelcher, M., Rohrer, J., Riedl, R., & Lehmann, S. (2023). A novel surface functionalization platform to prime extracellular vesicles for targeted therapy and diagnostic imaging. Nanomedicine: Nanotechnology, Biology and Medicine, 47(102607). https://doi.org/10.1016/j.nano.2022.102607
Other publications
Sabani B, Brand M, Albert I, Inderbitzin J, Eichenseher F, Schmelcher M, Rohrer J, Riedl R, Lehmann S. A novel surface functionalization platform to prime extracellular vesicles for targeted therapy and diagnostic imaging. Nanomedicine. 2023 Jan;47:102607. doi: 10.1016/j.nano.2022.102607. Epub 2022 Sep 24. PMID: 36167305.